Related Experiment Video
Updated: Apr 26, 2026
09:31
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
9.6K
Truncated and modified amyloid-beta species.
Markus P Kummer1, Michael T Heneka2
1Department of Neurology, University Hospital Bonn, Sigmund-Freud-Strasse 25, 53127 Bonn, Germany.
Alzheimer'S Research & Therapy
|July 18, 2014
Summary
Alzheimer's disease involves amyloid precursor protein (APP) processing into various amyloid-beta (Aβ) peptides. These peptides, modified post-translationally, influence disease progression through diverse properties.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Alzheimer's disease (AD) pathology is linked to amyloid precursor protein (APP) processing.
- Amyloid-beta (Aβ) peptides, formed from APP, aggregate into senile plaques, a hallmark of AD.
- Soluble Aβ forms also exist in biological fluids, contributing to disease mechanisms.
Purpose of the Study:
- To explore the diverse nature of amyloid-beta (Aβ) peptides resulting from amyloid precursor protein (APP) processing.
- To understand the structural variations and post-translational modifications of Aβ peptides.
- To investigate how these peptide variations may influence Alzheimer's disease progression.
Main Methods:
- Analysis of amyloid precursor protein (APP) processing pathways.
- Characterization of amyloid-beta (Aβ) peptide isoforms, including N- and C-termini.
- Identification and analysis of post-translational modifications (PTMs) on Aβ peptides.
Main Results:
- APP processing generates a variety of amyloid-beta (Aβ) peptides with diverse N- and C-termini.
- Aβ peptides include portions of the juxtamembrane and transmembrane domains of APP.
- Post-translational modifications (e.g., oxidation, phosphorylation, pyroglutamylation) create numerous Aβ variants.
Conclusions:
- The heterogeneity of amyloid-beta (Aβ) peptides, arising from APP processing and PTMs, is extensive.
- These diverse Aβ peptide forms possess distinct physiological and pathological properties.
- Understanding Aβ peptide diversity is crucial for comprehending and potentially modulating Alzheimer's disease progression.
Related Concept Videos
03:03Amyloid Fibrils
5.2K
5.2K
03:03Amyloid Fibrils
10.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.1K
01:23Alzheimer Disease ll: Pathophysiology
27
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
27